{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:19:17Z","timestamp":1792088357363,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s11882-006-0061-0","type":"journal-article","created":{"date-parts":[[2007,7,4]],"date-time":"2007-07-04T19:41:35Z","timestamp":1183578095000},"page":"282-288","source":"Crossref","is-referenced-by-count":26,"title":["Urticaria pigmentosa and mastocytosis: The role of immunophenotyping in diagnosis and determining response to treatment"],"prefix":"10.1007","volume":"6","author":[{"given":"Cem","family":"Akin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"61_CR1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.med.55.091902.103822","volume":"55","author":"C Akin","year":"2004","unstructured":"Akin C, Metcalfe DD: Systemic mastocytosis. Annu Rev Med, 2004, 55:419\u2013432.","journal-title":"Annu Rev Med"},{"key":"61_CR2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0145-2126(01)00050-9","volume":"25","author":"L Escribano","year":"2001","unstructured":"Escribano L, Diaz-Agustin B, Bellas C, et al.: Utility of.ow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis. Leuk Res 2001, 25:563\u2013570.","journal-title":"Leuk Res"},{"key":"61_CR3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","volume":"25","author":"P Valent","year":"2001","unstructured":"Valent P, Horny H, Escribano L, et al.: Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001, 25:603\u2013625. Original proposal of diagnostic criteria for systemic mastocytosis that was then adopted by WHO. Includes a detailed discussion of classification and diagnostic criteria.","journal-title":"Leuk Res"},{"key":"61_CR4","first-page":"166","volume":"3","author":"P Ehrlich","year":"1879","unstructured":"Ehrlich P: Beitrage zur Kenntniss der granulirten Bindegewebezellen und der eosinophilen Leukocythen. Arch Anat Physiol Physiol Abt 1879, 3:166.","journal-title":"Arch Anat Physiol Physiol Abt"},{"key":"61_CR5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0145-2126(01)00029-7","volume":"25","author":"CY Li","year":"2001","unstructured":"Li CY: Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry. Leuk Res 2001, 25:537\u2013541.","journal-title":"Leuk Res"},{"key":"61_CR6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0145-2126(01)00020-0","volume":"25","author":"LB Schwartz","year":"2001","unstructured":"Schwartz LB: Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders. Leuk Res 2001, 25:553\u2013562.","journal-title":"Leuk Res"},{"key":"61_CR7","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","volume":"316","author":"LB Schwartz","year":"1987","unstructured":"Schwartz LB, Metcalfe DD, Miller JS, et al.: Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987, 316:1622\u20131626.","journal-title":"N Engl J Med"},{"key":"61_CR8","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000478-199809000-00013","volume":"22","author":"HP Horny","year":"1998","unstructured":"Horny HP, Sillaber C, Menke D, et al.: Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol 1998, 22:1132\u20131140. Excellent reference illustrating the value of immunohistochemical staining for tryptase.","journal-title":"Am J Surg Pathol"},{"key":"61_CR9","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaci.2004.02.032","volume":"113","author":"S Jogie-Brahim","year":"2004","unstructured":"Jogie-Brahim S, Min HK, Fukuoka Y, et al.: Expression of alpha-tryptase and beta-tryptase by human basophils. J Allergy Clin Immunol 2004, 113:1086\u20131092.","journal-title":"J Allergy Clin Immunol"},{"key":"61_CR10","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood.V98.7.2200","volume":"98","author":"WR Sperr","year":"2001","unstructured":"Sperr WR, Jordan JH, Baghestanian M, et al.: Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood 2001, 98:2200\u20132209.","journal-title":"Blood"},{"key":"61_CR11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1067\/mai.2002.121454","volume":"109","author":"B Foster","year":"2002","unstructured":"Foster B, Schwartz LB, Devouassoux G, et al.: Characterization of mast-cell tryptase-expressing peripheral blood cells as basophils. J Allergy Clin Immunol 2002, 109:287\u2013293.","journal-title":"J Allergy Clin Immunol"},{"key":"61_CR12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/0145-2126(85)90119-5","volume":"9","author":"SJ Gadd","year":"1985","unstructured":"Gadd SJ, Ashman LK: A murine monoclonal antibody speci.c for a cell-surface antigen expressed by a subgroup of human myeloid leukaemias. Leuk Res 1985, 9:1329\u20131336. First description of the YB5.B8 antibody, which was later discovered to recognize (CD117).","journal-title":"Leuk Res"},{"key":"61_CR13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/icb.1987.27","volume":"65","author":"G Mayrhofer","year":"1987","unstructured":"Mayrhofer G, Gadd SJ, Spargo LD, Ashman LK: Specificity of a mouse monoclonal antibody raised against acute myeloid leukaemia cells for mast cells in human mucosal and connective tissues. Immunol Cell Biol 1987, 65:241\u2013250.","journal-title":"Immunol Cell Biol"},{"key":"61_CR14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0145-2126(88)90021-5","volume":"12","author":"AC Cambareri","year":"1988","unstructured":"Cambareri AC, Ashman LK, Cole SR, Lyons AB: A monoclonal antibody to a human mast cell\/myeloid leukaemia-specific antigen binds to normal haemopoietic progenitor cells and inhibits colony formation in vitro. Leuk Res 1988, 12:929\u2013939.","journal-title":"Leuk Res"},{"key":"61_CR15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0046-8177(98)90066-1","volume":"29","author":"DA Arber","year":"1998","unstructured":"Arber DA, Tamayo R, Weiss LM: Specific section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol 1998, 29:498\u2013504.","journal-title":"Hum Pathol"},{"key":"61_CR16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2567.1996.493578.x","volume":"87","author":"H Agis","year":"1996","unstructured":"Agis H, Fureder W, Bankl HC, et al.: Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology 1996, 87:535\u2013543. Detailed immunophenotypic analysis of mast cells.","journal-title":"Immunology"},{"key":"61_CR17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10428190400010775","volume":"46","author":"P Valent","year":"2005","unstructured":"Valent P, Akin C, Sperr W, et al.: Mastocytosis: pathology, genetics, and current options for therapy. Leuk Lymphoma 2005, 46:35\u201348.","journal-title":"Leuk Lymphoma"},{"key":"61_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaci.2004.04.046","volume":"114","author":"C Akin","year":"2004","unstructured":"Akin C, Metcalfe DD: The biology of Kit in disease and the application of pharmacogenetics. J Allergy Clin Immunol 2004, 114:13\u201319; quiz 20.","journal-title":"J Allergy Clin Immunol"},{"key":"61_CR19","first-page":"291","volume-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid Tissues","author":"P Valent","year":"2001","unstructured":"Valent P, Horny HP, Li CY, et al.: Mastocytosis. In World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid Tissues. Edited by Jaffe ES, et al. Lyon: IARC Press; 2001:291\u2013302."},{"key":"61_CR20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/adc.86.5.315","volume":"86","author":"MC Carter","year":"2002","unstructured":"Carter MC, Metcalfe DD: Paediatric mastocytosis. Arch Dis Child 2002, 86:315\u2013319.","journal-title":"Arch Dis Child"},{"key":"61_CR21","doi-asserted-by":"crossref","first-page":"47S","DOI":"10.1111\/1523-1747.ep12469034","volume":"96","author":"RI Parker","year":"1991","unstructured":"Parker RI: Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease. J Invest Dermatol 1991, 96:47S-51S.","journal-title":"J Invest Dermatol"},{"key":"61_CR22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000048188","volume":"127","author":"M Castells","year":"2002","unstructured":"Castells M, Austen KF: Mastocytosis: mediator-related signs and symptoms. Int Arch Allergy Immunol 2002, 127:147\u2013152.","journal-title":"Int Arch Allergy Immunol"},{"key":"61_CR23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00277-002-0575-z","volume":"81","author":"L Escribano","year":"2002","unstructured":"Escribano L, Akin C, Castells M, et al.: Mastocytosis: current concepts in diagnosis and treatment. Ann Hematol 2002, 81:677\u2013690.","journal-title":"Ann Hematol"},{"key":"61_CR24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/1097-0142(19880901)62:5<965::AID-CNCR2820620520>3.0.CO;2-M","volume":"62","author":"WD Travis","year":"1988","unstructured":"Travis WD, Li CY, Yam LT, et al.: Significance of systemic mast cell disease with associated hematologic disorders. Cancer 1988, 62:965\u2013972.","journal-title":"Cancer"},{"key":"61_CR25","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0889-8588(03)00089-3","volume":"17","author":"P Valent","year":"2003","unstructured":"Valent P, Akin C, Sperr WR, et al.: Mast cell proliferative disorders: current view on variants recognized by the World Health Organization. Hematol Oncol Clin North Am 2003, 17:1227\u20131241.","journal-title":"Hematol Oncol Clin North Am"},{"key":"61_CR26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0145-2126(02)00168-6","volume":"27","author":"P Valent","year":"2003","unstructured":"Valent P, Akin C, Sperr WR, et al.: Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk Res 2003, 27:635\u2013641.","journal-title":"Leuk Res"},{"key":"61_CR27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0145-2126(01)00044-3","volume":"25","author":"K Wolff","year":"2001","unstructured":"Wolff K, Komar M, Petzelbauer P: Clinical and histopathological aspects of cutaneous mastocytosis. Leuk Res 2001, 25:519\u2013528.","journal-title":"Leuk Res"},{"key":"61_CR28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.iac.2004.01.002","volume":"24","author":"K Brockow","year":"2004","unstructured":"Brockow K: Urticaria pigmentosa. Immunol Allergy Clin North Am 2004, 24:287\u2013316.","journal-title":"Immunol Allergy Clin North Am"},{"key":"61_CR29","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","volume":"92","author":"H Nagata","year":"1995","unstructured":"Nagata H, Worobec AS, Oh CK, et al.: Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci U S A, 1995, 92:10560\u201310564.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"61_CR30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0145-2126(01)00041-8","volume":"25","author":"WR Sperr","year":"2001","unstructured":"Sperr WR, Escribano L, Jordan JH, et al.: Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Leuk Res 2001, 25:529\u2013536.","journal-title":"Leuk Res"},{"key":"61_CR31","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","volume":"91","author":"L Escribano","year":"1998","unstructured":"Escribano L, Orfao A, Diaz-Agustin B, et al.: Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood, 1998, 91:2731\u20132736. First report of immunophenotypic abnormalities in mastocytosis. Findings in this report provided the basis for the immunophenotypic diagnostic criterion of systemic mastocytosis.","journal-title":"Blood"},{"key":"61_CR32","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1309\/CX45R79PCU9HCV6V","volume":"124","author":"M Krokowski","year":"2005","unstructured":"Krokowski M, Sotlar K, Krauth MT, et al.: Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia. Am J Clin Pathol 2005, 124:560\u2013568. Immunohistochemical detection of CD25 in bone marrow sections.","journal-title":"Am J Clin Pathol"},{"key":"61_CR33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0022-1759(80)90085-X","volume":"33","author":"T Nakagawa","year":"1980","unstructured":"Nakagawa T, Stadler BM, De Weck AL: Determination of rat mast cells by flow-cytometry. J Immunol Methods 1980, 33:87\u201392.","journal-title":"J Immunol Methods"},{"key":"61_CR34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000057747","volume":"127","author":"M Ghannadan","year":"2002","unstructured":"Ghannadan M, Hauswirth AW, Schernthaner GH, et al.:Detection of novel CD antigens on the surface of human mast cells and basophils. Int Arch Allergy Immunol 2002, 127:299\u2013307.","journal-title":"Int Arch Allergy Immunol"},{"key":"61_CR35","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1189\/jlb.0604349","volume":"77","author":"S Florian","year":"2005","unstructured":"Florian S, Ghannadan M, Mayerhofer M, et al.: Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1. J Leukoc Biol 2005, 77:984\u2013992.","journal-title":"J Leukoc Biol"},{"key":"61_CR36","first-page":"1493","volume":"149","author":"A Orfao","year":"1996","unstructured":"Orfao A, Escribano L, Villarrubia J, et al.: Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: Identification and enumeration. Am J Pathol 1996, 149:1493\u20131499.","journal-title":"Am J Pathol"},{"key":"61_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.10072","volume":"58","author":"L Escribano","year":"2004","unstructured":"Escribano L, Diaz-Agustin B, Lopez A, et al.: Immunophenotypic analysis of mast cells in mastocytosis: when and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA). Cytometry B Clin Cytom 2004, 58:1\u20138. A comprehensive discussion of techniques and recommendations for.ow cytometric analysis of mast cells in mastocytosis.","journal-title":"Cytometry B Clin Cytom"},{"key":"61_CR38","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1365-2141.2003.04125.x","volume":"120","author":"A Pardanani","year":"2003","unstructured":"Pardanani A, Kimlinger TK, Reeder TL, et al.: Differential expression of CD2 on neoplastic mast cells in patients with systemic mast cell disease with and without an associated clonal haematological disorder. Br J Haematol 2003, 120:691\u2013694.","journal-title":"Br J Haematol"},{"key":"61_CR39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0320(19970415)30:2<98::AID-CYTO4>3.0.CO;2-9","volume":"30","author":"L Escribano","year":"1997","unstructured":"Escribano L, Orfao A, Villarrubia J, et al.: Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry 1997, 30:98\u2013102.","journal-title":"Cytometry"},{"key":"61_CR40","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","volume":"101","author":"AD Klion","year":"2003","unstructured":"Klion AD, Noel P, Akin C, et al.: Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue.brosis, poor prognosis, and imatinib responsiveness. Blood 2003, 101:4660\u20134666. First description of immunophenotypic mast cell abnormalities in FIP1L1-PDGFRA-associated myeloproliferative disease (chronic eosinophilic leukemia).","journal-title":"Blood"},{"key":"61_CR41","doi-asserted-by":"crossref","unstructured":"Florian S, Esterbauer H, Binder T, et al.: Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SMCEL): detection of FIP1L1\/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib. Leuk Res 2006, E-pub ahead of print.","DOI":"10.1016\/j.leukres.2005.11.014"},{"key":"61_CR42","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","volume":"103","author":"C Akin","year":"2004","unstructured":"Akin C, Fumo G, Yavuz AS, et al.: A novel form of mastocytosis associated with a transmembrane c-Kit mutation and response to imatinib. Blood, 2004, 103:3222\u20133225. Immunophenotypic analysis of the morphologic variant of welldifferentiated mastocytosis.","journal-title":"Blood"},{"key":"61_CR43","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood.V98.13.3784","volume":"98","author":"GH Schernthaner","year":"2001","unstructured":"Schernthaner GH, Jordan JH, Ghannadan M, et al.:Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells. Blood, 2001, 98:3784\u20133792.","journal-title":"Blood"},{"key":"61_CR44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2141.2003.04055.x","volume":"120","author":"R Nunez-Lopez","year":"2003","unstructured":"Nunez-Lopez R, Escribano L, Schernthaner GH, et al.:Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis. Br J Haematol 2003, 120:257\u2013265.","journal-title":"Br J Haematol"},{"key":"61_CR45","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0145-2126(02)00073-5","volume":"26","author":"L Escribano","year":"2002","unstructured":"Escribano L, Perez de Oteyza J, Nunez R, Orfao A: Cladribine induces immunophenotypical changes in bone marrow mast cells from mastocytosis. Report of a case of mastocytosis associated with a lymphoplasmacytic lymphoma. Leuk Res 2002, 26:1043\u20131046.","journal-title":"Leuk Res"},{"key":"61_CR46","first-page":"139","volume":"295","author":"E Buchdunger","year":"2000","unstructured":"Buchdunger E, Cioffi CL, Law N, et al.: Abl proteintyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and plateletderived growth factor receptors. J Pharmacol Exp Ther 2000, 295:139\u2013145.","journal-title":"J Pharmacol Exp Ther"},{"key":"61_CR47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2003-08-2798","volume":"103","author":"AD Klion","year":"2004","unstructured":"Klion AD, Robyn J, Akin C, et al.: Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood 2004, 103:473\u2013478.","journal-title":"Blood"},{"key":"61_CR48","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2005-07-3022","volume":"107","author":"KV Gleixner","year":"2006","unstructured":"Gleixner KV, Mayerhofer M, Aichberger KJ, et al.: PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects. Blood 2006, 107:752\u2013759.","journal-title":"Blood"},{"key":"61_CR49","doi-asserted-by":"crossref","unstructured":"Shah NP, Lee FY, Luo R, et al.: Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in the majority of patients with systemic mastocytosis. Blood 2006, Epub ahead of print.","DOI":"10.1182\/blood-2005-10-3969"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-006-0061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-006-0061-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-006-0061-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T01:30:00Z","timestamp":1587691800000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-006-0061-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["61"],"URL":"https:\/\/doi.org\/10.1007\/s11882-006-0061-0","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}